University Hospitals Seidman Cancer Center Offers Excellent, Expert Care for Patients with Thyroid Cancer

Thyroid cancer is a slow progressing cancer and has a 97 percent five-year survival rate. Still, if you have been diagnosed with thyroid cancer and have anxiety and questions, we understand how you may feel. According to the American Cancer Society, an estimated 45,000 new cases of thyroid cancer are diagnosed each year in the U.S. Younger women between the ages of 20 and 55 account for 75 percent of these new cases. UH Seidman Cancer Center’s physicians are experts at diagnosing and treating thyroid cancer, working together to tailor treatment to each patient’s individual needs.

University Hospitals Seidman Cancer Center is a nationally recognized innovator in the treatment of head and neck cancerous and noncancerous tumors.

Our advanced treatments include:

  • Minimally invasive surgery through endoscopy
  • Reconstructive techniques to preserve quality of life
  • Targeted chemotherapy
  • Precise radiation therapy
  • Access to advanced clinical trials

Nationally Recognized Cancer Team Puts Patients First

UH Seidman Cancer Center is a nationally recognized cancer program with expertise in both routine and complex care for every stage of thyroid cancer. Our patients benefit from a team approach to their cancer care. Our multidisciplinary team performs a disease-specific tumor board review each week. Every single patient has the resources of an entire team of national experts to guide thyroid cancer care decisions. This review process ensures that all realistic treatment options are considered. The following specialists may be involved in the review, care and treatment of thyroid cancer patients:

  • Genetic counselors
  • Medical geneticists
  • Medical oncologists
  • Nurse navigators
  • Nurse practitioners
  • Otolaryngologists (ENT doctors)
  • Oral surgeons
  • Pathologists
  • Radiation oncologists
  • Radiologists
  • Social workers
  • Surgical oncologists

Award-Winning Cancer Program

UH Seidman Cancer Center is part of the Case Comprehensive Cancer Center, which is designated by the National Cancer Institute as one of only 41 Comprehensive Cancer Centers in the country. Our outstanding team evaluates and reviews every cancer case so diagnosis and treatment decisions are based on the knowledge of our team of experts. The close relationships between researchers and care providers guarantee that the latest research findings are interpreted into effective cancer treatments as quickly as possible.

UH Seidman Cancer Center has been nationally recognized as a top 20 cancer center year after year, according to U.S. News & World Report hospital rankings.

Thyroid Cancer Clinical Trials

UH Seidman Cancer Center has many available clinical trials for patients with thyroid cancer, including:

  • Studying the safety of radiation therapy plus chemo with or without a cancer drug for thyroid cancer. Learn more.
  • Using two chemo drugs to treat tumors not cured by standard treatment. Learn more.